Geovax Labs Inc (OTCMKTS:GOVX)’s stock price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.39 and traded as high as $0.79. Geovax Labs shares last traded at $0.74, with a volume of 325,292 shares.
The firm has a 50-day moving average of $0.55 and a 200 day moving average of $0.39.
Geovax Labs (OTCMKTS:GOVX) last released its quarterly earnings results on Tuesday, May 5th. The biotechnology company reported ($0.13) EPS for the quarter. The company had revenue of $0.72 million during the quarter.
GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform in the United States and internationally. It is developing various preventive vaccines against human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for chronic Hepatitis B infections and cancers.
Further Reading: Oversold
Receive News & Ratings for Geovax Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Geovax Labs and related companies with MarketBeat.com's FREE daily email newsletter.